Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial
収録刊行物
-
- The Lancet Respiratory Medicine
-
The Lancet Respiratory Medicine 10 (4), 327-336, 2022-04
Elsevier BV